Previous Article | Next Article ![]()
Journal of Bacteriology, January 2001, p. 178-188, Vol. 183, No. 1
Division of Infectious Diseases,
Massachusetts General Hospital, Boston, Massachusetts
02114,1 and Department of Microbiology
and Molecular Genetics, Harvard Medical School, Boston, Massachusetts
021152
Received 28 June 2000/Accepted 3 October 2000
ToxT, a member of the AraC family of transcriptional regulators,
controls the expression of several virulence factors in Vibrio cholerae. In the classical biotype of V. cholerae,
expression of toxT is regulated by the same environmental
conditions that control expression of the virulence determinants
cholera toxin and the toxin coregulated pilus. Several genes that
activate toxT expression have been identified. To identify
genes that repress toxT expression in nonpermissive
environmental conditions, a genetic screen was used to isolate
mutations which alter the expression of a toxT-gusA
transcriptional fusion. Several mutants were isolated, and the mutants
could be divided into two classes. One class of mutants exhibited
higher expression levels of toxT-gusA at both the
nonpermissive pH and temperature, while the second class showed elevated toxT-gusA expression only at the nonpermissive pH.
One mutant from the second class was chosen for further
characterization. This mutant was found to carry a TnphoA
insertion in a homolog of the Escherichia coli pepA gene.
Disruption of pepA in V. cholerae resulted in
elevated levels of expression of cholera toxin, tcpA, toxT, and tcpP at the noninducing pH but not at
the noninducing temperature. Elevated levels of expression of
toxT and tcpP at the nonpermissive pH in the
pepA mutant were abolished in tcpP toxR mutant
and aphB mutant backgrounds, respectively. A putative binding site for PepA was identified in the tcpPH-tcpI
intergenic region, suggesting that PepA may act at the level of
tcpPH transcription. Disruption of pepA caused
only partial deregulation at the noninducing pH, suggesting the
involvement of additional factors in the pH regulation of virulence
genes in V. cholerae.
Vibrio cholerae is a
gram-negative bacillus that is the etiologic agent for the diarrheal
illness cholera. Most epidemics of cholera are caused by strains
belonging to serotype O1, which can be divided into classical and El
Tor biotypes (28). Cholera toxin and the toxin-coregulated
pilus (TCP) are among the important V. cholerae virulence
factors. Cholera toxin is a heterodimeric secreted protein which
consist of two subunits, A and B. The A subunit is enzymatically active
and causes elevation of intracellular cyclic AMP (cAMP). A pentamer of
B subunits, associated with a single A subunit, binds the holotoxin to
the ganglioside GM1 receptor on eukaryotic cells (17, 18,
35). The genes that encode cholera toxin, ctxA and
ctxB, are arranged as an operon and are contained within the
genome of a filamentous bacteriophage, CTX ToxT, a member of the AraC family of transcriptional regulators,
controls the transcription of the ctxAB and the
tcp operons (15, 24). The toxT gene
is contained within the tcp gene cluster, and
toxT transcription occurs as part of the tcp
operon, as well as from a promoter immediately upstream of
toxT itself (3). Activation of toxT
transcription depends on two pairs of proteins, ToxR-ToxS and
TcpP-TcpH, which act synergistically at the toxT promoter
(7, 22). ToxR is a transmembrane protein with an amino-terminal, cytoplasmic DNA-binding domain that acts as a transcriptional activator, while ToxS encodes a periplasmic protein that facilitates dimerization and activation of ToxR (14, 41, 42,
44). TcpP is a transmembrane protein, which, like ToxR, has
homology with members of the bacterial two-component family of response
regulators (22). TcpH, which is encoded by a gene that
forms an operon with tcpP, enhances the activity of TcpP as
a transcriptional activator of toxT (7).
Recently, expression of the tcpPH operon has been shown to
be positively regulated by the proteins AphA and AphB. AphA has no
known homolog in the database, while AphB is homologous to members of
the LysR family of transcriptional regulators (30, 47).
Due to the important role of ToxR in activating virulence genes and
because it was the first regulator identified, the regulatory circuit
controlling virulence gene expression in V. cholerae is called the ToxR regulon. The current model for controlling virulence gene expression in V. cholerae is that of a regulatory
cascade (13). According to this model, AphA and AphB
activate expression of TcpP and TcpH which, in turn, act
synergistically with ToxR and ToxS to positively regulate
toxT expression. Finally, ToxT activates expression of its
dependent genes, which are collectively called the ToxT-dependent
branch of the ToxR regulon, leading to production of cholera toxin and
TCP. A different branch of the ToxR regulon involves the direct control
of expression of the outer membrane proteins OmpU and OmpT by ToxR, and
this branch is called the ToxT-independent branch (9, 11, 15,
32).
Expression of cholera toxin and TCP, and of their activator ToxT, in
classical strains of V. cholerae is strongly regulated by
environmental signals, such as pH, temperature, amino acid concentration, and osmolarity (43, 44). The environmental conditions that activate expression of V. cholerae virulence
genes are called ToxR-inducing conditions (30°C and pH 6.5), whereas conditions of pH 8.4 and 37°C, termed ToxR-noninducing conditions, result in repression of the regulon (43). Expression of
the tcpPH operon in the classical cholera strain is
regulated by the same environmental conditions that regulate expression
of the ToxT-dependent branch of the ToxR regulon, whereas expression of
toxR has been shown to be constitutive in different
environmental conditions. These observations have led to the proposal
that the regulated expression of tcpPH couples environmental
signals to the expression of toxT and ToxT-dependent genes
(7).
As described above, significant knowledge exists about the role of
transcriptional activators of virulence genes in V. cholerae. However, surprisingly little information is available
about the mechanisms used by the bacterium to sense its environment and the regulatory pathways that transduce these signals to affect regulation of the ToxR regulon in different environmental conditions, particularly the regulatory signals that repress expression in nonpermissive environmental conditions. Recently, it was reported that
disruption of the genes, cya and crp, which
encode adenylate cyclase (cAMP) and the cAMP receptor protein (CRP),
respectively, in a classical V. cholerae strain derepresses
the expression of cholera toxin and TCP at the nonpermissive pH of 8.4 (46). A putative consensus binding site for the cAMP-CRP
complex overlaps the The present study was undertaken to identify additional negative
regulators of the ToxR regulon. To isolate mutants showing altered
expression of the toxT promoter in the noninducing
environmental conditions, we performed transposon mutagenesis on a
classical strain of V. cholerae carrying a
toxT-gusA transcriptional fusion. By inserting the
toxT-gusA fusion within lacZ, separate from the rest of the tcpA operon, we hoped to identify novel genes
exerting direct transcriptional control over either toxT
expression or one of its regulators upstream in the regulatory cascade,
and not genes such as cya or crp, that act at the
tcpA promoter. Here, we report the identification of several
mutants causing deregulated toxT-gusA expression at either
the noninducing pH or the noninducing temperature, and we present a
detailed characterization of one of them, a homolog of pepA
from Escherichia coli that mediates negative regulation of
the ToxR regulon at the noninducing pH in V. cholerae.
Bacterial strains, plasmids, and media.
Bacterial strains
and plasmids used in this study are shown in Table
1. All strains were maintained at
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.1.178-188.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
pepA, a Gene Mediating pH Regulation of
Virulence Genes in Vibrio cholerae

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, that lysogenizes
V. cholerae (36, 56). The second major V. cholerae virulence factor, TCP, is a type IV pilus. A cluster of
12 genes are involved in the processing and assembly of the pilus on
the surface of the bacterium. The major subunit of TCP is encoded by
tcpA and the tcp gene cluster is expressed as an operon from a promoter upstream of tcpA (3,
50). The genes of the tcp operon, as well as adjacent
genes, have recently been shown to be encoded by another filamentous
bacteriophage, VPI
(29).
35 sequence of the tcpA promoter, and
in the crp mutant, derepression of ctx expression
also occurs in the toxR background. Therefore, the authors
of that study hypothesized that the cAMP-CRP complex acts as a
repressor at the level of toxT expression, perhaps by
modulating activity at the tcpA promoter. According to this model, disruption of cya or crp would derepress
tcpA from pH regulation, causing increased expression of
toxT, and consequently cholera toxin and TCP, as a result of
increased readthrough transcription from the upstream tcpA
promoter (46).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C in Luria-Bertaini (LB) medium containing 15% glycerol. LB
medium contained 10 g of tryptone, 5 g of yeast extract, and
5 g of NaCl per liter. Ampicillin (25 or 100 µg/ml),
streptomycin (100 µg/ml), tetracycline (15 µg/ml), or kanamycin (45 µg/ml) were added as appropriate.
TABLE 1.
Strains and plasmids used in this study
In vitro manipulation of DNA. Restriction analyses and cloning were done by standard techniques as described earlier (2). Enzymatic reagents were purchased from New England Biolabs (Beverley, Mass.) or Boehringer Mannheim (Indianapolis, Ind.) and used as specified by the manufacturer. Amplification of DNA by PCR was carried out as previously described (26).
Construction of a chromosomal toxT-gusA fusion.
A 761-bp toxT promoter-containing fragment that extends from
within the tcpF gene to the start codon of toxT
was PCR amplified from O395 using the primer pair RT19B
(5'-AAAGGATCCTATGATATTGTGAATGTTGGTGGTG-3', BamHI site underlined) and PAC59
(5'-AAACAGGATTTCTATATACATTAGTTTGAAAAG-3'; PstI site underlined) and cloned into the
BglII and PstI sites of plasmid pUJ10. The
phoA gene in pUJ10 was replaced with the promoterless
gusA gene, encoding
-glucuronidase, from plasmid pWM2
(37), to create plasmid pJB4. The DNA fragment containing the toxT-gusA fusion was excised by digestion with
XbaI and NotI and cloned into pT689, to yield
plasmid pJB6. Plasmid pJB6 was introduced into O395 by electroporation,
and the toxT::gusA fusion was exchanged
by double homologous recombination into the lacZ gene as
previously described (6), resulting in strain JB29. Insertion of the fusion into the chromosome at the lacZ
locus was confirmed by Southern blot analysis.
TnphoA mutagenesis and determination of sequences
adjacent to transposon insertions.
A library of random transposon
insertion mutants derived from strain JB29 was constructed by
TnphoA mutagenesis as previously described
(51). Appropriate dilutions of the mutant library were
plated onto LB agar plates, at pH 8.4, containing 40 µg of X-glucuronidase (Sigma Chemical Co., St. Louis, Mo.) per ml and incubated for 48 h at 30°C. Colonies that appeared blue on
plates, reflecting elevated toxT-gusA expression under these
noninducing conditions, were isolated for further characterization by
quantitative
-glucuronidase assays.
Strain constructions.
To construct a polar mutation in the
pepA gene, a 938-bp XbaI-EcoRI
fragment was amplified by PCR from the O395 chromosome with the primer
pair JB29R (5'-GCGGTGATCTAGAGGGTAAAC-3';
XbaI site underlined) and JB30L
(5'-CAACGGAATTCAGTACGTCACACA-3';
EcoRI site underlined), ligated to
XbaI-EcoRI-digested suicide vector pGP704, and
transformed into E. coli DH5
pir to create
plasmid pJB10. The recombinant plasmid was mobilized into JB29 and
YM2-34 by conjugation, using the E. coli donor strain
SM10
pir, to create strains JB98 and JB104, respectively.
Disruption of the pepA locus was verified by Southern blot analysis.
Assays.
-Glucuronidase assays were performed as described
previously, with some minor modifications (27). For
toxT-gusA fusion-containing strains, overnight cultures
(approximately 16 h of incubation) were used for
-glucuronidase
assays. Assays were performed by harvesting 500 µl of bacterial
culture, pelleting the cells by centrifugation, washing them once with
50 mM phosphate buffer (pH 7.0), and resuspending the cells in 500 µl
of phosphate buffer. Cell were lysed (20 to 250 µl, depending on the
expected
-glucuronidase activity) by vortexing them for 20 s
after the addition of 10 µl of toluene. The volume of the reaction
tubes was brought up to 900 µl with 50 mM phosphate buffer, and
samples incubated at 37°C for 10 min.
p-Nitrophenyl-
-D-glucuronide (100 µl;
Sigma) was added to start the reactions, and the samples were incubated at 37°C for 20 to 60 min. Reactions were stopped by the addition of
400 µl of 3 M 2-amino-2-methylpropanediol (Sigma), vortexed for
20 s, and centrifuged for 10 min, and the absorbance of the supernatants at 420 nm was measured. Similar assays were performed with
the tcpP-gusA fusion-containing strains, except that
overnight cultures in LB medium were subcultured the next day and
samples harvested after 6 h of incubation at the inducing or
noninducing conditions (expression of the fusion in inducing conditions
was highest at this time point). Cholera toxin was assayed in culture supernatants after overnight growth in inducing or noninducing conditions, using GM-1 enzyme-linked immunosorbent assay (ELISA) as
previously described (25).
Protein analysis. Total cell lysates prepared from V. cholerae cells grown to stationary phase overnight were diluted 1:100 in distilled water, and the protein concentration was determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, Calif.). For immunoblot analysis, 40 µg of each protein sample was subjected to electrophoresis on a 15% polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. The membrane was probed with a polyclonal rabbit anti-TcpA antibody (a gift of John J. Mekalanos) overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit antibody (Amersham Pharmacia Biotech, Piscataway, N.J.) for 1 h. The blot was developed using the ECL kit (Amersham Pharmacia) exposed to film for up to 1 min.
Nucleotide sequence accession number. The sequence of the V. cholerae O395 pepA gene has been deposited in the GenBank database under accession no. AF282267.
| |
RESULTS |
|---|
|
|
|---|
Isolation of mutants showing deregulated expression of
toxT in noninducing environmental conditions.
To
isolate mutants of V. cholerae exhibiting enhanced
toxT expression in noninducing growth conditions, we
constructed a pool of approximately 50,000 independent
TnphoA insertion mutants derived from the parental strain
JB29. Subsequently, the mutant pool was plated onto LB agar plates,
with the pH adjusted to 8.4 and containing 40 µg of the chromogenic
substrate X-glucuronidase per ml, and incubated at 30°C for 48 h. Normally, growth of the parental strain JB29 at pH 8.4 and 30°C
represses expression of toxT-gusA and colonies are white on
the indicator medium for the first 24 to 48 h. We were interested
in isolating colonies that appeared blue, since they might represent
mutants exhibiting elevated toxT expression in noninducing
conditions. Of the several dozen mutants initially isolated from
plates, 16 reproducibly showed increased
-glucuronidase activity in
noninducing conditions in quantitative liquid assays and were chosen
for further analysis.
JB62, JB65, JB66, JB69, JB70, and
JB73
yielded sufficient sequence information to enable us to identify
the site of transposon insertion by similarity searches.
These mutants were characterized further with regard to
toxT-gusA expression in different environmental conditions
(Fig. 1). Based on the
-glucuronidase
activities at either the noninducing pH or temperature, the six mutants
could be divided into two groups. The first group, which included JB65,
JB66, and JB70, showed slightly higher
-glucuronidase activities
than the control at the noninducing pH but significantly higher
activities at the noninducing temperature. For reasons that are
unclear, JB70 reproducibly expressed very low levels of
toxT-gusA in inducing conditions. All three strains in this
group showed significant growth defects and, with the exception of the
growth of JB66 at pH 8.4, grew too poorly in all conditions tested for
us to assess their agglutination phenotypes.
|
Sequence analysis of the pepA gene.
We utilized
PCR amplification and sequencing of the junctional fragment with
TnphoA in JB69 and demonstrated that the transposon had
inserted within pepA (Fig. 2).
We searched the V. cholerae genome in the TIGR database and
located the complete sequence of pepA and the adjacent
chromosomal region. Analysis of an approximately 6-kb fragment in the
vicinity of pepA revealed four open reading frames (ORFs)
(Fig. 2). We identified the 447-bp coding region of a putative protein
82 bp downstream of pepA and transcribed in the same
orientation, which was 41% identical (49% similar) to the
subunit
of DNA polymerase III holoenzyme from E. coli encoded by
holC (accession no. P28905) (8). A third ORF, located 92 bp downstream of the holC homolog and oriented
similarly, encoded a 953-amino-acid putative protein with 75% amino
acid identity to valyl-tRNA-synthetase from E. coli
(accession no. P07118). A fourth ORF, located upstream of
pepA and transcribed divergently, encoded a putative protein
with 42% identity to a 40.4-kDa hypothetical transmembrane protein
from E. coli (accession no. P39340). The organization of
these four ORFs in V. cholerae is strikingly similar to that
of E. coli. Based on the significant similarity to E. coli genes and on their conserved arrangement on the chromosome,
we have named these ORFs pepA, holC, and
valS.
|
|
Effect of pepA disruption on toxT-gusA
expression.
To determine whether the phenotype of JB69 was
actually due to the insertion of TnphoA into the
pepA gene or to an unlinked second-site mutation or polar
effect on a downstream gene, we constructed additional pepA
mutations in the toxT-gusA fusion strain JB29. Strain JB98
was created by forcing integration of a pepA internal
fragment cloned in suicide vector pGP704, into the chromosome of JB29
at the pepA locus, thereby disrupting the ORF after codon
362. Analysis of toxT-gusA expression in JB98 revealed the
same phenotype as the transposon mutant JB69, with approximately
threefold-higher expression of the fusion in cultures grown at the
nonpermissive pH of 8.4 (Fig. 4). It is
worth noting that JB69 and JB98 still exhibited some residual
regulation at pH 8.4, with toxT-gusA expression levels at pH
8.4 approximately 50% of those at pH 6.5, suggesting that classical
V. cholerae may have regulatory pathways mediating pH
regulation of toxT expression independently of
pepA. Importantly, the disruption of pepA
resulted in neither any difference in the maximal levels of
toxT-gusA expression in inducing conditions (pH 6.5, 30°C)
compared to the parent strain, nor did it influence the negative
regulation of the fusion by the nonpermissive temperature. Similarly,
when cultures were incubated at the nonpermissive conditions of 37°C
and pH 8.4, expression was downregulated to the same extent as with the
wild-type strain. These results suggest that pepA mediates
negative regulation of toxT expression at the noninducing pH
but not at the noninducing temperature.
|
Deregulated expression of cholera toxin and TcpA at pH 8.4 in
pepA mutants.
ToxT controls the expression of the two
major virulence factors of V. cholerae, cholera toxin and
the TCP (15). Since disruption of pepA caused
elevated toxT expression at the noninducing pH, we
hypothesized that deregulated expression of ToxT at pH 8.4 should also
result in elevated expression of the genes controlled by it. To test
whether the deregulated toxT expression in pepA mutants was similarly reflected in regulation of cholera toxin production, we performed cholera toxin ELISAs on culture supernatants of the pepA mutants grown in various conditions (Fig.
5A). Cholera toxin production in strains
JB98 and JB123, containing the polar and in-frame pepA
deletions, respectively, was only slightly elevated in inducing
conditions or at the noninducing temperature. However, when the strains
were grown at the noninducing pH, cholera toxin expression was three-
to fourfold higher in the pepA mutants than in the control.
Interestingly, the expression of cholera toxin was not completely
deregulated in the pepA mutants, a finding that is
consistent with our results from toxT-gusA expression assays.
|
Mutation in pepA does not change the requirement for
ToxR and TcpP for toxT expression.
As mentioned above,
the expression of toxT is dependent on the transcriptional
activators ToxR and TcpP. The results suggesting that the
pepA gene product functions as a negative regulator of virulence gene expression led us to question whether disruption of
pepA could cause elevated expression of toxT at
pH 8.4 in the absence of ToxR or TcpP. We tested this possibility
directly by constructing disruptions in either toxR or
tcpP in the wild-type and pepA backgrounds and
then assaying toxT-gusA expression in different conditions
of pH and temperature. Disruption of either toxR or
tcpP in the wild-type background resulted in dramatically lower levels of expression of the fusion in all four growth conditions (Fig. 6). Expression levels in the double
mutants were also very low and comparable to those of the single
mutants. These results suggest that loss of PepA function does not
change the requirement for the transcriptional activators ToxR and TcpP
for toxT expression in either inducing or noninducing
conditions and raise the possibility that PepA may act indirectly on
toxT, through either toxR or tcpP. However, our results do not exclude the possibility that PepA may act
at more than one level in the virulence gene regulatory cascade.
|
Disruption of pepA partially relieves negative regulation of tcpP expression by noninducing pH. Recent reports from our own and other laboratories have established the important role of TcpP and TcpH in transcription of toxT in classical V. cholerae (7, 22). Transcription of tcpPH in classical V. cholerae is regulated by pH and temperature, while the expression of toxR has been shown to be constitutive in different environmental conditions. These observations have led to the hypothesis that regulated expression of TcpP and TcpH may couple environmental growth conditions to transcription of toxT and ToxT-dependent virulence genes in V. cholerae (7).
Our observations that pepA mutants showed partially defective pH regulation of toxT and its dependent genes raised the possibility that pepA may be necessary for negative regulation of tcpPH expression at pH 8.4. To test this hypothesis, we constructed a polar pepA disruption and an in-frame pepA deletion in the strain YM2-34 (45), which contains a tcpP-gusA fusion cloned in the lacZ locus in a classical V. cholerae background, resulting in the strains JB104 and JB132, respectively. When these pepA mutant strains were grown in LB medium, pH 6.5, no significant difference in the levels of
-glucuronidase
activity were found compared to the parental control (Fig.
7). However, when cultures were grown at
the noninducing pH of 8.4, JB104 and JB132 expressed
-glucuronidase activity at levels approximately twofold higher than did YM2-34, suggesting that pepA disruption partially relieves the
negative regulation of tcpPH expression at the noninducing
pH. These same two mutants also agglutinate in the nonpermissive pH,
similar to the results described above.
|
pepA) and in the
parental strain, JB29. As shown in Fig. 7, disruption of
aphB dramatically reduced expression of the
tcpP-gusA fusion at both the inducing and the noninducing pH
in the aphB single mutant, as well as in the pepA
aphB double mutant, suggesting that AphB is required for
transcriptional activation of tcpPH even in the absence of
the negative regulator, PepA. These results, along with those presented
above, lead us to conclude that pepA mediates pH regulation
of the ToxT-dependent branch of the ToxR regulon by acting as a
negative regulator at a level upstream of tcpPH
transcription in the virulence gene regulatory cascade in classical
V. cholerae.
The V. cholerae lap gene does not mediate pH regulation of the ToxR regulon. Recently, Toma and Honma reported the identification of a V. cholerae gene, lap, encoding a 501-amino-acid protein with homology to the Vibrio proteolyticus aminopeptidase and showed that this was an active leucine aminopeptidase by the ability of the recombinant lap gene product to cleave the substrate leucyl-p-nitroanilide (53). The lap gene was found by PCR analysis to be widely distributed among V. cholerae strains but was absent in other bacterial species examined. While the pepA gene identified in our screen encodes a protein with homology to leucine aminopeptidases from E. coli and other species, there is no sequence similarity between it and the V. cholerae lap gene. To test whether the lap gene, like pepA, also mediates environmental regulation of virulence gene expression in V. cholerae, we engineered a disruption in lap by insertional mutagenesis with the suicide plasmid pJB12, creating the strain JB115. Analysis of toxT-gusA expression and agglutination of JB115 in cultures grown at either the nonpermissive pH or temperature revealed no difference between JB115 and the parental strain JB29 (data not shown). Thus, the lap gene product, unlike that of pepA, does not appear to have a role in pH regulation of the ToxR regulon.
| |
DISCUSSION |
|---|
|
|
|---|
The expression of virulence determinants in classical strains of V. cholerae is coordinately regulated by several regulatory proteins and is strongly influenced by signals derived from the host and the environment. We report here the identification of two classes of transposon-generated mutants showing altered regulation of toxT and its dependent genes when grown at a noninducing pH or noninducing temperature. The successful isolation of several different mutants exhibiting deregulated pH and temperature control suggests that environmental regulation of virulence genes in V. cholerae is a complex process involving multiple genes and regulatory pathways. While several positive regulators of the ToxR regulon in V. cholerae have been identified, we know little about negative regulation of this regulon. We demonstrate here that pepA acts as a negative regulator of virulence determinants at the noninducing pH, suggesting that downregulation of gene expression in nonpermissive conditions may also play an important role in controlling the ToxR regulon. The fact that disruption of pepA deregulates pH but not temperature regulation of toxT also suggests that these two environmental signals are perceived differently by the organism and have separable signaling pathways in the bacterium.
It is now well established that many pathogenic bacteria have evolved from related nonpathogenic species by acquiring virulence genes that remain clustered together on the bacterial chromosome, forming pathogenicity islands (31). Since these horizontally acquired genes are often regulated by the same environmental signals that regulate non-virulence-associated genes, it is possible that horizontally acquired genes may utilize or adapt to existing regulatory circuits modulating gene expression in response to environmental cues. Therefore, it is not surprising that the horizontally acquired, phage-encoded ctxAB and tcp operons in V. cholerae have acquired regulation by genes such as toxR that are located elsewhere on the primordial bacterial chromosome. Evidence for the regulation of accessory genetic elements by ancestral chromosomal components, such as cAMP and CRP (46), AphA and AphB (30, 47), and the NQR complex (23), points toward a significant interplay between the metabolic and virulence functions of this bacterium. PepA appears to be another example of an ancestral chromosomal gene that is involved in the regulation of phage-encoded virulence genes and presumably has other cellular metabolic functions besides regulation of virulence genes, as has been hypothesized for ToxR and cAMP-CRP.
The pepA gene product in E. coli is a multifunctional protein. It has been shown to be an active leucine aminopeptidase (55), a member of the multiprotein complex that resolves plasmid multimers into monomers to result in heritable stability of plasmid ColE1 (48), and a repressor in the pyrimidine-mediated negative regulation of the carAB operon that encodes carbamoylphosphate synthetase (10). Recently, a role for PhpA, the P. aeruginosa homolog of PepA, was demonstrated in the regulation of virulence determinants. Disruption of phpA in an algB genetic background resulted in increased expression of the alginate biosynthetic operon, suggesting that phpA may act as a negative regulator of virulence-associated genes in this pathogenic bacterium as well (57).
Considering the fact that PepA homologs serve a remarkably wide range of functions, there are several possible ways in which PepA could exert a negative regulatory effect on the ToxR regulon in V. cholerae. The regulatory role of PepA could be dependent on its enzymatic activity and could depend on an exopeptidase activity to activate a target repressor protein, or inactivate a transcriptional activator of tcpPH, at the noninducing pH. For example, the removal of an N-terminal methionine residue results in the activation of glutamine phosphoribosylpyrophosphate aminotransferase that requires an N-terminal cysteine residue for its activity (54). AphA and AphB have been shown to activate tcpPH expression but do not appear to be strongly regulated themselves by the environmental signals that modulate tcpPH transcription (30, 47). It is conceivable that PepA could act directly or indirectly to modify AphA or AphB activity. However, by analogy with E. coli, it appears less likely that the role of aminopeptidase as a pH regulator in V. cholerae is dependent on its enzymatic activity. Aminopeptidases have broad substrate specificity and can cleave N-terminal amino acids from peptides of various sizes and sequences (38, 39), making it less likely that there are specific targets for PepA activity. Moreover, it has been demonstrated that the aminopeptidase activity of PepA in E. coli is separable from its regulatory function and that the aminopeptidase activity is not required for either plasmid ColE1 Xer site-specific recombination or for the repression of the carAB operon (10, 34). However, it is possible that the regulatory role of PepA may be dependent on the degradation or modification of a peptide that functions as an inducer or repressor of the ToxR regulon or as a signaling molecule in specific environmental conditions.
Another intriguing possibility is that PepA may mediate pH regulation
by functioning as a DNA-binding protein and directly affecting
transcription. In E. coli, PepA has been conclusively shown
to be a sequence-specific DNA-binding protein involved both in the
regulation of carAB, the carbamoylphosphate synthetase operon, and as an autorepressor at the pepA promoter
(10). Sequence alignment of five experimentally identified
DNA-binding sites of PepA, three of which are shown in Fig.
8, has revealed that a number of
positions that are AT-rich are strongly conserved (10).
There are two PepA target sites, 25 to 30 bp in length and 65 nucleotides apart, in the carAB operon in E. coli
and Salmonella enterica serovar Typhimurium and in the ColEI
cer site but only one site in the promoter region of the
pepA gene itself. Based on the consensus sequence proposed
by Charlier et al. (10), we have identified a putative
PepA target site in the tcpPH-tcpI intergenic region (Fig.
8). This site is centered 133 bp upstream of the tcpPH
transcriptional start site and 49 bp upstream of the tcpI
transcriptional start (45). In the classical biotype, the
putative target sequence matches the consensus in 9 of 10 positions,
while in the El Tor biotype, it matches the consensus in 8 of 10 positions (Fig. 8).
|
We speculate that PepA could act by binding to this putative target site in the tcpPH control region and interfering with transcriptional regulation. It is also possible that binding of PepA to the target site could interfere with the expression of tcpI, which in turn may be involved in regulating other genes in the ToxR regulon. Whether, in fact, PepA can directly bind to the tcpPH promoter and repress its activity either by inducing changes in DNA topology or by potentially competing with AphA or AphB for target sites in the tcpI-tcpPH intergenic region is currently under investigation. We are also investigating whether expression of pepA itself is regulated by environmental cues in V. cholerae.
Our results showing that disruption of the lap gene, encoding another V. cholerae leucine aminopeptidase with no sequence homology to PepA, does not alter regulation of toxT are consistent with the conclusion that PepA has distinct regulatory roles not shared by other cellular aminopeptidases. E. coli and serovar Typhimurium have several different aminopeptidases (39, 40). In serovar Typhimurium, metabolic analysis of strains carrying mutations in the genes encoding aminopeptidases A, B, D, and N suggests that the enzymes function to break down exogenously supplied peptides for use as nutrients. In addition, they degrade endogenous peptides generated from cleavage of cellular protein. However, only PepA appears to have additional regulatory functions in Xer recombination and regulation of pyrimidine biosynthesis (10, 38, 39).
We have isolated several mutants that show deregulated toxT expression at the noninducing pH alone or at both the noninducing pH and the noninducing temperature. As yet, we do not know the precise role of the genes disrupted in these deregulated mutants. It is possible that one or more of these genes may participate in the same control pathway as PepA. In E. coli, cer site-specific recombination involves a multiprotein complex in which PepA appears to serve an accessory role (49). Therefore, it is possible that PepA may play a role as a member of a protein complex that controls gene regulation at the noninducing pH, and disruption of pepA would interfere with the regulation mediated by this complex. This model would also explain why only partial deregulation at the noninducing pH is observed in pepA mutants, since the loss of PepA would result in defective pH sensing but perhaps not the total loss of function of the pH-sensing complex.
| |
ACKNOWLEDGMENTS |
|---|
We thank Barry Wanner, William Metcalf, and Patrick Piggot for the gift of plasmids and John Mekalanos for the anti-TcpA antibody. We also thank Joan Butterton, Yvette Murley, Camille Kotton, and members of the Calderwood laboratory for the gift of reagents and helpful advice and Costi Sifri for comments on the manuscript.
This work was supported by a grant from the National Institute of Allergy and Infectious Diseases, RO1 AI44487, to S.B.C.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. Phone: (617) 726-3811. Fax: (617) 726-7416. E-mail: scalderwood{at}partners.org.
Present address: Department of Internal Medicine, UMass Memorial
Medical Center, Worcester, MA 01605.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[CrossRef][Medline]. |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1994. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y. |
| 3. | Brown, R. C., and R. K. Taylor. 1995. Organization of tcp, acf, and toxT genes within a ToxT-dependent operon. Mol. Microbiol. 16:425-439[CrossRef][Medline]. |
| 4. | Burley, S. K., P. R. David, R. M. Sweet, A. Taylor, and W. N. Lipscomb. 1992. Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin. J. Mol. Biol. 224:113-140[CrossRef][Medline]. |
| 5. | Butterton, J. R., D. T. Beattie, C. L. Gardel, P. A. Carroll, T. Hyman, K. P. Killeen, J. J. Mekalanos, and S. B. Calderwood. 1995. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 63:2689-2696[Abstract]. |
| 6. | Butterton, J. R., E. T. Ryan, D. W. Acheson, and S. B. Calderwood. 1997. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect. Immun. 65:2127-2135[Abstract]. |
| 7. | Carroll, P. A., K. T. Tashima, M. B. Rogers, V. J. DiRita, and S. B. Calderwood. 1997. Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae. Mol. Microbiol. 25:1099-1111[CrossRef][Medline]. |
| 8. | Carter, J. R., M. A. Franden, J. A. Lippincott, and C. S. McHenry. 1993. Identification, molecular cloning and characterization of the gene encoding the chi subunit of DNA polymerase III holoenzyme of Escherichia coli. Mol. Gen. Genet. 241:399-408[Medline]. |
| 9. | Champion, G. A., M. N. Neely, M. A. Brennan, and V. J. DiRita. 1997. A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains. Mol. Microbiol. 23:323-331[CrossRef][Medline]. |
| 10. | Charlier, D., G. Hassanzadeh, A. Kholti, D. Gigot, A. Pierard, and N. Glansdorff. 1995. carP, involved in pyrimidine regulation of the Escherichia coli carbamoylphosphate synthetase operon encodes a sequence-specific DNA-binding protein identical to XerB and PepA, also required for resolution of ColEI multimers. J. Mol. Biol. 250:392-406[CrossRef][Medline]. |
| 11. | Crawford, J. A., J. B. Kaper, and V. J. DiRita. 1998. Analysis of ToxR-dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae. Mol. Microbiol. 29:235-246[CrossRef][Medline]. |
| 12. |
de Lorenzo, V.,
M. Herrero,
U. Jakubzik, and K. N. Timmis.
1990.
Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.
J. Bacteriol.
172:6568-6572 |
| 13. | DiRita, V. J. 1992. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6:451-458[Medline]. |
| 14. | DiRita, V. J., and J. J. Mekalanos. 1991. Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation. Cell 64:29-37[CrossRef][Medline]. |
| 15. |
DiRita, V. J.,
C. Parsot,
G. Jander, and J. J. Mekalanos.
1991.
Regulatory cascade controls virulence in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
88:5403-5407 |
| 16. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317 |
| 17. | Gill, D. M. 1976. The arrangement of subunits in cholera toxin. Biochemistry 15:1242-1248[CrossRef][Medline]. |
| 18. |
Gill, D. M., and R. Meren.
1978.
ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.
Proc. Natl. Acad. Sci. USA
75:3050-3054 |
| 19. |
Goldberg, M. B.,
S. A. Boyko, and S. B. Calderwood.
1991.
Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
88:1125-1129 |
| 20. | Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580[Medline]. |
| 21. | Harrison, R. W., J. C. Miller, M. J. D'Souza, and G. Kampo. 1997. Easy gene walking. BioTechniques 22:650-653[Medline]. |
| 22. |
Hase, C. C., and J. J. Mekalanos.
1998.
TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
95:730-734 |
| 23. |
Hase, C. C., and J. J. Mekalanos.
1999.
Effects of changes in membrane sodium flux on virulence gene expression in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
96:3183-3187 |
| 24. |
Higgins, D. E.,
E. Nazareno, and V. J. DiRita.
1992.
The virulence gene activator ToxT from Vibrio cholerae is a member of the AraC family of transcriptional activators.
J. Bacteriol.
174:6974-6980 |
| 25. |
Holmgren, J.
1973.
Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
Infect. Immun.
8:851-859 |
| 26. | Innis, M. A., D. H. Gelfand, J. J. Sninsky, and T. J. White. 1990. PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, Calif. |
| 27. |
Jefferson, R. A.,
S. M. Burgess, and D. Hirsh.
1986.
-Glucuronidase from Escherichia coli as a gene-fusion marker.
Proc. Natl. Acad. Sci. USA
83:8447-8451 |
| 28. | Kaper, J. B., J. G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86[Abstract]. (Erratum, 8:316.) |
| 29. | Karaolis, D. K., S. Somara, D. R. Maneval, Jr., J. A. Johnson, and J. B. Kaper. 1999. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399:375-379[CrossRef][Medline]. |
| 30. |
Kovacikova, G., and K. Skorupski.
1999.
A Vibrio cholerae LysR homolog, AphB, cooperates with AphA at the tcpPH promoter to activate expression of the ToxR virulence cascade.
J. Bacteriol.
181:4250-4256 |
| 31. | Lee, C. A. 1996. Pathogenicity islands and the evolution of bacterial pathogens. Infect. Agents Dis. 5:1-7[Medline]. |
| 32. | Li, C. C., J. A. Crawford, V. J. DiRita, and J. B. Kaper. 2000. Molecular cloning and transcriptional regulation of ompT, a ToxR-repressed gene in Vibrio cholerae. Mol. Microbiol. 35:189-203[CrossRef][Medline]. |
| 33. |
Mazel, D.,
B. Dychinco,
V. A. Webb, and J. Davies.
1998.
A distinctive class of integron in the Vibrio cholerae genome.
Science
280:605-608 |
| 34. | McCulloch, R., M. E. Burke, and D. J. Sherratt. 1994. Peptidase activity of Escherichia coli aminopeptidase A is not required for its role in Xer site-specific recombination. Mol. Microbiol. 12:241-251[CrossRef][Medline]. |
| 35. |
Mekalanos, J. J.,
R. J. Collier, and W. R. Romig.
1979.
Enzymic activity of cholera toxin. I. New method of assay and the mechanism of ADP-ribosyl transfer.
J. Biol. Chem.
254:5849-5854 |
| 36. | Mekalanos, J. J., D. J. Swartz, G. D. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551-557[CrossRef][Medline]. |
| 37. |
Metcalf, W. W., and B. L. Wanner.
1993.
Construction of new -glucuronidase cassettes for making transcriptional fusions and their use with new methods for allele replacement.
Gene
129:17-25[CrossRef][Medline].
|
| 38. |
Miller, C. G.
1975.
Genetic mapping of Salmonella typhimurium peptidase mutations.
J. Bacteriol.
122:171-176 |
| 39. |
Miller, C. G., and K. Mackinnon.
1974.
Peptidase mutants of Salmonella typhimurium.
J. Bacteriol.
120:355-363 |
| 40. |
Miller, C. G., and G. Schwartz.
1978.
Peptidase-deficient mutants of Escherichia coli.
J. Bacteriol.
135:603-611 |
| 41. |
Miller, V. L.,
V. J. DiRita, and J. J. Mekalanos.
1989.
Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter.
J. Bacteriol.
171:1288-1293 |
| 42. |
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475 |
| 43. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 44. | Miller, V. L., R. K. Taylor, and J. J. Mekalanos. 1987. Cholera toxin transcriptional activator ToxR is a transmembrane DNA binding protein. Cell 48:271-279[CrossRef][Medline]. |
| 45. |
Murley, Y. M.,
J. Behari,
R. Griffin, and S. B. Calderwood.
2000.
Classical and El Tor biotypes of Vibrio cholerae differ in timing of transcription of tcpPH during growth in inducing conditions.
Infect. Immun.
68:3010-3014 |
| 46. |
Skorupski, K., and R. K. Taylor.
1997.
Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
94:265-270 |
| 47. | Skorupski, K., and R. K. Taylor. 1999. A new level in the Vibrio cholerae ToxR virulence cascade: AphA is required for transcriptional activation of the tcpPH operon. Mol. Microbiol. 31:763-771[CrossRef][Medline]. |
| 48. | Stirling, C. J., S. D. Colloms, J. F. Collins, G. Szatmari, and D. J. Sherratt. 1989. xerB, an Escherichia coli gene required for plasmid ColE1 site-specific recombination, is identical to pepA, encoding aminopeptidase A, a protein with substantial similarity to bovine lens leucine aminopeptidase. EMBO J. 8:1623-1627[Medline]. |
| 49. | Summers, D. K. 1989. Derivatives of ColE1 cer show altered topological specificity in site-specific recombination. EMBO J. 8:309-315[Medline]. |
| 50. | Taylor, R., C. Shaw, K. Peterson, P. Spears, and J. Mekalanos. 1988. Safe, live Vibrio cholerae vaccines? Vaccine 6:151-154[CrossRef][Medline]. |
| 51. | Taylor, R. K., C. Manoil, and J. J. Mekalanos. 1989. Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae. J. Bacteri |